Accurate blood testing with capillary blood taken directly in the incubator, enables quick diagnosing and treatment

Hypoglycemia is a major risk during the neonatal period. The condition may compromise a child’s neurological development if left untreated. The situation for the new parents is very tough. Instead of enjoying family life safely at home as expected, they have to spend time in the high tech neonatal intensive care unit.  Feeling comfort and cared for may ease the worry and concerns.

A position of trust

As a professional within neonatal care, you are well aware of the risks that threaten the newborn, not least the risks associated with hypoglycemia. Newborns, especially premature, and those of low birth weight are vulnerable to disturbances in glucose metabolism. This is why a rapid, precise and accurate method of blood glucose determination is essential in the neonatal intensive care unit (NICU).

Accurate blood glucose testing with only capillary blood can be taken directly in the incubator minimize disturbance to neonatal babies. To immediate detect even the smallest change, allows for appropriate treatment to be started without unnecessary delay. Accurate point-of-care testing can give the extra time so well needed.

Solutions at hand

HemoCue point-of-care testing systems are available for rapid, precise, and accurate testing of blood glucose and hemoglobin. Small blood volumes and rapid turn-around-time make point-of-care testing extremely suitable in neonatal care.

  • Monitoring of glucose levels
  • Detection and monitoring of anemia


The HemoCue Glucose 201 RT System can be used for monitoring of neonatal blood glucose levels, but should not be used on critically ill neonates in neonatal intensive care settings. 


Cookies are used on this site

Use of cookies